Induction of Apoptosis in a Macrophage Cell Line RAW 264.7 By Acemannan, a β-(1,4)-Acetylated Mannan

  1. Lalitha Ramamoorthy and
  2. Ian R. Tizard
  1. Department of Veterinary Pathobiology, Texas A & M University, College Station, Texas 77843

    Abstract

    Acemannan is a polydispersed β-(1,4)-linked acetylated mannan with antiviral properties. It is an immunomodulator, and studies in our laboratory have shown that it causes activation of macrophages. In the presence of IFNγ, acemannan induced apoptosis in RAW 264.7 cells. These cells exhibited chromatin condensation, DNA fragmentation, and laddering characteristic of apoptosis. The induction of apoptosis by acemannan and IFNγ does not seem to be mediated by nitric oxide, since N-nitro-l-arginine methyl ester, the nitric oxide inhibitor, had no effect. Acemannan in the presence of IFNγ also inhibited the expression of bcl-2. These results suggest that acemannan in the presence of IFNγ induces apoptosis in RAW 264.7 cells through a mechanism involving the inhibition ofbcl-2 expression.

    Footnotes

    • Send reprint requests to: Lalitha Ramamoorthy, Dept. of Veterinary Pathobiology, Texas A&M University, College Station, TX 77843. E-mail: l0r7859{at}nigel.tamu.edu

    • This study was supported by a grant from Carrington Laboratories, Dallas, Texas. I.R.T. is a paid consultant for Carrington Laboratories.

    • Abbreviations:
      IFNγ
      interferon γ
      PBS
      phosphate-buffered saline
      SDS
      sodium dodecyl sulfate
      EGTA
      ethylene glycol bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
      PAGE
      polyacrylamide gel electrophoresis
      PVDF
      polyvinylidene difluoride
      PCR
      polymerase chain reaction
      DEPC
      diethylpyrocarbonate
      G3PD
      glyceraldehyde-3-phosphate dehydrogenase
      bp
      base pair(s)
      HEPES
      4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
      FITC
      fluorescein isothiocyanate
      l-NAME
      N-nitro-l-arginine methyl ester
      • Received June 23, 1997.
      • Accepted November 7, 1997.
    « Previous | Next Article »Table of Contents